Metabolic syndrome, type II diabetes and atherosclerosis congress
3rd Metabolic Syndrome, type II Diabetes and Atherosclerosis Meeting
Organizing Committee and Scientific Advisory Board
abstract submission MSDA 2006...
all scientific sessions...
Marrakesh May 24th to May 28th...
Chartered flight...
Congress Opening Ceremony
to receive your invitation for MSDA 2006...
Organizing Secreteriat and Congress Venue
 
PROGRAM
THURSDAY, MAY 25, 2006
12.30 p.m. – 02.00 p.m.
LUNCH DEBATE SPONSORED BY BAYER HEALTHCARE PHARMA   
Metabolic HTA: concept to reality
Co-chair by: J.-C. Fruchart (France)
 Title to be advised ................................................................................................................................ P. Valensi (France)
 Title to be advised ................................................................................................................................. B. Vaisse (France)
02.00 p.m. – 03.30 p.m.
ACADEMIC SESSION 2   
New perspectives for HDL-targeted therapies
Co-chair by: C. Calvo (Chile) & R. Ceska (Czek Republic)
spacer
 Pleiotropic functions of HDL ......................................................................................... A. Von Eckardstein (Switzerland)
 New pathways of cellular cholesterol efflux ................................................................................................ A. Tall (USA)
 HDL: a new target for the treatment of the metabolic syndrome and atherosclerosis ........................... B. Brewer (USA)
 Title to be advised ................................................................................................................... S. Santa-Marina Fojo (USA)